World Health Organization. World malaria report. Geneva: WHO; 2016. http://www.who.int/malaria/publications/world_malaria_report_2016/en/
Google Scholar
Liu Y, Zhang HW, Zhou RM, Yang CY, Qian D, Zhao YL, et al. First imported relapse case of Plasmodium vivax malaria and analysis of its origin CSP sequencing in Henan Province. China Malar J. 2014;13:448. doi:10.1186/1475-2875-13-448.
Article
PubMed
Google Scholar
Feng J, Yan H, Feng XY, Zhang L, Li M, Xia ZG et al. Imported malaria in China, 2012. Emerg Infect Dis, 2014;20:1778-1780. doi:org/10.1186/1475-2875-13-29.
Zhang HW, Su YP, Zhao XD, Yan QY, Liu Y, Chen JS. [Imported falciparum malaria situation in Henan Province during 2005-2009] (In chinese). Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2010;28: 476-477.
World Health Organization. Guidelines for the treatment of malaria. Geneva: WHO; 2006.
Google Scholar
Wang LQ, Liu YH, Zhao SX, Yang ZQ. [advances in the study of artemisinin resistance in Plasmodium falciparum and methods of its detection] (in chinese). Journal of Pathogen Biology. 2014;9:1142–4. doi:10.13350/j.cjpb.141221.
Google Scholar
Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–20. doi:10.1056/NEJMc0805011.
Article
CAS
PubMed
Google Scholar
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, et al. Artemisinin Resistance in Plasmodium falciparum Malaria. N Engl J Med. 2009;361:455–67. doi:10.1056/NEJMoa0808859.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muller O, Sie A, Meissner P, Schirmer RH, Kouyate B. Artemisinin resistance on the Thai-Cambodian border. Lancet. 2009;374:1419. doi:10.1016/S0140-6736(09)61857-2.
Article
PubMed
Google Scholar
Wang ZL, Shrestha S, Li XL, Miao J, Yuan LL, Cabrera M, Grube C, Yang ZQ, Cui LW. Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007–2012. Malar J. 2015;14:168. doi:10.1186/s12936-015-0672-9.
Article
PubMed
PubMed Central
Google Scholar
Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, et al. Independent emergence of Artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2014; 211:670–679. doi:https://doi.org/10.1093/infdis/jiu491.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, et al. A molecular marker of artemisininresistant Plasmodium falciparum malaria. Nature. 2014;505:50–5. doi:10.1038/nature12876.
Article
PubMed
Google Scholar
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–23. doi:10.1056/NEJMoa1314981.
Article
PubMed
PubMed Central
Google Scholar
Feng J, Li J, Yan H, Feng MY, Xia ZG. Evaluation of Antimalarial resistance marker polymorphism in returned migrant Workers in China. Antimicrob Agents Chemother. 2015;59:326–30. doi:10.1128/AAC.04144-14.
Article
PubMed
Google Scholar
World Health Organization. Artemisinin and artemisinin-based combination therapy resistance. Geneva: WHO; http://apps.who.int/iris/bitstream/10665/250294/1/WHO-HTM-GMP-2016.11-eng. pdf.
Zhang MH, Lu F, Cao J, Gao Q. [progress in researches on molecular markers of Plasmodium falciparum drug resistance] (in Chinese). Chin J Schisto Control. 2015;27:323–7. doi:10.16250/j.32.1374.2014227.
Google Scholar
Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, Tagbor H, Williams J, Bojang K, Njie F, et al. Absence of putative Artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:680–8. doi:10.1093/infdis/jiu467.
Article
PubMed
Google Scholar
Nyunt MH, Hlaing T, Oo HW, Tin-Oo LK, Phway HP, Wang B, Zaw NN, Han SS, Tun T, San KK, et al. Molecular assessment of artemisinin-resistance markers, polymorphisms in the K13 propeller and a multidrug-resistance gene, in eastern and western border areas of Myanmar. Clin Infect Dis. 2015;60:1208–15. doi:10.1093/cid/ciu1160.
Article
CAS
PubMed
Google Scholar
Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, Lin K, Kyaw MP, Plewes K, Faiz MA, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:416-421. doi:org/10.1016/S1473-3099(15)70032-0.
Aye A. Win AA, Imwong M, Kyaw MP, Woodrow CJ, Chotivanich K, Hanboonkunupakarn B, Pukrittayakamee S. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar. Malar J 2016; 15:110. doi: org/10.1093/cid/ciu1160.
Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;37:2453–64. doi:10.1056/NEJMoa1513137.
Article
Google Scholar
Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, Mumba D, Kekre M, Yavo W, Mead D, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2015;211:1352–5. doi:10.1093/infdis/jiu608.
PubMed
Google Scholar
Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, Dionne P, Fall KB, Diatta B, Diemé Y, et al. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013. Malar J. 2014;13:472. doi:10.1186/1475-2875-13-472.
Article
PubMed
PubMed Central
Google Scholar
Sylla K, Abiola A, Kouly Tine RC, Faye B, Sow D, Ndiaye JL, Ndiaye M, LO AC, Folly K, Ndiaye LA, et al. Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance. Malar J. 2013;13:598. doi:10.1186/1471-2334-13-598.
Google Scholar
Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002; 2:209–218. doi: http://dx.doi.org/10.1016/S1473-3099(02)00239-6.
WHO. The application of artemisinin monotherapies for malaria treatment was demanded to end by WHO (In Chinese). ADRJ.2006;8:152.
Antimalarial drug policy in China. http://www.nhfpc.gov.cn/zwgkzt/wsbysj/200907/41610.shtml.
Chinese Center for Disease Control and Prevention. China’s technical scheme of malaria elimination. Beijing: Chinese Center for Disease Control and Prevention; 2011.
Google Scholar
Feng J, Xiao HH, Xia ZG, Zhang L, Xiao N. Analysis of malaria epidemiological characteristics in the People's Republic of China, 2004-2013. Am J Trop Med Hyg. 2015;93:293–9. doi:10.4269/ajtmh.14-0733.
Article
PubMed
PubMed Central
Google Scholar
Zhang L, Zhou SS, Feng J, Fang W, Xia ZG. [malaria situation in the people’ s republic of China in 2014] (in Chinese). Chin J Parasitol Parasit Dis. 2015;33:321–6.
Google Scholar
Feng J, Zhou DL, Lin YX, Xiao HH, Yan H, Xia ZG. Amplification of pfmdr1, pfcrt, pvmdr1, and K13 propeller polymorphisms associated with Plasmodium falciparum and Plasmodium vivax isolates from the China-Myanmar border. Antimicrob Agents Chemother. 2015;59:2554–9. doi:10.1128/AAC.04843-14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL. Molecular mutation profile of pfcrt in plasmodium falciparum isolates imported from Africa in Henan province. Malar J. 2016;15:265. doi:10.1186/s12936-016-1306-6.
Article
PubMed
PubMed Central
Google Scholar
Yang CY, Qian D, Chen WQ, Liu Y, Zhou RM, Zhang HW, et al. Chin J Schisto Control. 2016;28:444–6. doi:10.16250/j.32.1374.2015200.
Google Scholar
Mvumbi DM, Kayembe J, Situakibanza H, BobangaTL, Nsibu CN, Mvumbi GL, Melin P, Mol PD, Hayette M. Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review. Malar J. 2015; 14:354. doi: 10.1186/s12936-015-0892-z.